Citation:Eggermont AM, Chiarion-Sileni V, Grob JJ, Dummer R, Wolchok JD, Schmidt H, et al 2015

From Cancer Guidelines Wiki

Citation


Eggermont AM, Chiarion-Sileni V, Grob JJ, Dummer R, Wolchok JD, Schmidt H, et al. Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial. Lancet Oncol 2015 May;16(5):522-30 Available from: http://www.ncbi.nlm.nih.gov/pubmed/25840693.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
What is the role of adjuvant systemic therapy in patients with resected stage II and stage III melanoma?Tamsin Parrishcompleted
What is the role of adjuvant systemic therapy in patients with resected stage II and stage III melanoma?Cecilia Taingcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What is the role of adjuvant systemic therapy in patients with resected melanoma?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the role of adjuvant systemic therapy in patients with resected melanoma?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What is the role of adjuvant systemic therapy in patients with resected melanoma?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the role of adjuvant systemic therapy in patients with resected melanoma?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. What is the appropriate treatment of macroscopic (i.e. detectable clinically or by ultrasound) nodal metastases?
  2. What is the role of adjuvant systemic therapy in patients with resected stage II and stage III melanoma?